ACTINIUM PHARMACEUTICALS, INC.
Last · —$0.975-0.025 (-2.50%)live · yahoo · 1s ago
Market cap$30.64M—
P/E · TTM2.7fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | $35.1M |
|---|---|
| Operating income | $21.7M |
| Net income | $22.4M |
| Free cash flow | $-11.5M |
| Operating margin | 61.7% |
| Net margin | 63.8% |
| Return on equity | 73.9% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-30
- Sbc Revenue High
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Sbc Revenue High — SBC/Revenue 10211.1%
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -37652.2%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -27311.1%
- Cash Runway Low — Cash runway ~2.0 years
- Accumulated Deficit High — Accumulated deficit / equity 5230%
- Rd Intensity High — R&D/Revenue 23471.1%